Cancer Prevention News and Highlights
National Lung Screening Trial Reaches Goal of 50,000 Participants
Community Clinical Oncology Program Celebrates 20 Years
New Addition to DCP: Clinical Trials Resource Website
Diagnostic Criteria for Hereditary Non-Polyposis Colorectal Cancer and Microsatellite Instability: The Revised Bethesda Guidelines
NCI-Funded Clinical Trials Show Aspirin Reduces Recurrence of Polyps, March 05, 2003
Early Reproductive Events and Breast Cancer, February 20, 2003
National Lung Screening Trial launched Sept. 18, 2002: 50,000 Current and Former Smokers Needed for Study
First-Year SELECT Data: Enrollment Statistics
DCP Changes from Master Agreement Holders to a Consortium concept: Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Preclinical In Vitro and In Vivo Screening Assays for Cancer Prevention Agent Development
Report from Large NCI Study Suggests PSA Testing Could Be Done at Longer Intervals for Men Who Choose to Test
Large-scale Genotyping for the Haplotype Map of the Human Genome
Aspirin May Reduce Risk of Colon Polyps
Protein Patterns May Identify Ovarian Cancer
NCI Statement on Mammography Screening
Breast Cancer Prevention Study STAR Reaches Mid-Point of Recruitment
Interview with Dr. Leslie Ford about STAR
DCP grantee recognized by TIME magazine as one of "America's Best" clinical scientists
PLCO Cancer Screening Trial Completes Recruitment
Largest-Ever Prostate Cancer Prevention Trial Opens: 32,000 Men Sought to Test Vitamin E and Selenium
Best Leads for Prostate Cancer Prevention Appear in April Urology Supplement
HPV Testing Shows Which Pap Abnormalities Need Attention
General Motors Teams Up with Cancer Researchers to Take a Step Toward Breast Cancer Prevention
HOME
|
DICTIONARY
|
SITE MAP
|
SEARCH
ACCESSIBILITY
|
PRIVACY POLICY
|
CONTACT DCP